Literature DB >> 11481564

Serial changes on quantitative myocardial perfusion SPECT in patients undergoing revascularization or conservative therapy.

D S Berman1, X Kang, E F Schisterman, J Gerlach, P B Kavanagh, J S Areeda, T Sharir, S W Hayes, L J Shaw, H C Lewin, J D Friedman, R Miranda, G Germano.   

Abstract

BACKGROUND: Little is known about changes of myocardial perfusion in patients undergoing coronary revascularization or medical therapy. The purpose of this observational study was to assess the long-term effects of revascularization or conservative therapy on serial quantitative myocardial perfusion single photon emission computed tomography (SPECT). METHODS AND
RESULTS: The study population consisted of 421 patients who underwent serial rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion SPECT with at least a 1-year interval between the 2 studies and who had abnormal quantitative scan results on the first stress SPECT. The mean interval between scans was 32.7 +/- 15.9 months. Patients were divided into 3 groups according to stress defect extent: group 1 had small stress defects (4%-10%, n = 145), group 2 had intermediate stress defects (>10%-20%, n = 144), and group 3 had extensive stress defects (>20%, n = 132) at baseline. Forty patients in group 1, 44 in group 2, and 54 in group 3 underwent coronary revascularization between 2 SPECT studies; the others had conservative therapy. In group 3 patients with revascularization, stress defect extent and reversible defect extent were remarkably reduced (14.5% +/- 13.6% and 13.1% +/- 12.5%, respectively; both P <.0001), with greater improvement in those patients reporting increased use of cardiac medications; resting defect extent was slightly reduced (1.9% +/- 6.4%, P <.05). In group 3 patients with conservative therapy, a small reduction in stress defect extent was noted (2.3% +/- 8.3%, P <.05). In group 2, there were modest, similar reductions in reversible defect extent in both the patients with revascularization (2.7% +/- 7.7%, P <.05) and those with conservative therapy (1.8% +/- 7.3%, P <.05), as well as a small but significant reduction in stress defect extent in those with conservative therapy (2.1% +/- 8.2%, P <.05). In group 1 patients, no significant changes in stress, rest, or reversible defect extent were found with either therapy.
CONCLUSIONS: The findings of this study show that improvement in quantitative myocardial perfusion abnormalities over time occurs in some patients with either revascularization or conservative therapy and suggest that, in patients with extensive defects, greater improvement may be seen in those who undergo revascularization.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11481564     DOI: 10.1067/mnc.2001.113991

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  37 in total

1.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

2.  Incremental prognostic value of rest-redistribution (201)Tl single-photon emission computed tomography.

Authors:  T Sharir; D S Berman; H C Lewin; J D Friedman; I Cohen; R Miranda; R D Agafitei; G Germano
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

3.  Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction.

Authors:  R Hachamovitch; D S Berman; L J Shaw; H Kiat; I Cohen; J A Cabico; J Friedman; G A Diamond
Journal:  Circulation       Date:  1998-02-17       Impact factor: 29.690

4.  Quantitative analysis of technetium 99m 2-methoxyisobutyl isonitrile single-photon emission computed tomography and isosorbide dinitrate infusion in assessment of myocardial viability before and after revascularization.

Authors:  S T Li; X J Liu; Z L Lu; R F Shi; X D Zhu; W Q Chen; Q W Wu; Y Z Liu
Journal:  J Nucl Cardiol       Date:  1996 Nov-Dec       Impact factor: 5.952

5.  Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography.

Authors:  D S Berman; R Hachamovitch; H Kiat; I Cohen; J A Cabico; F P Wang; J D Friedman; G Germano; K Van Train; G A Diamond
Journal:  J Am Coll Cardiol       Date:  1995-09       Impact factor: 24.094

6.  Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study.

Authors:  D S Berman; H Kiat; J D Friedman; F P Wang; K van Train; L Matzer; J Maddahi; G Germano
Journal:  J Am Coll Cardiol       Date:  1993-11-01       Impact factor: 24.094

7.  Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease.

Authors:  A S Iskandrian; S C Chae; J Heo; C D Stanberry; V Wasserleben; V Cave
Journal:  J Am Coll Cardiol       Date:  1993-09       Impact factor: 24.094

8.  Intensive medical therapy versus coronary angioplasty for suppression of myocardial ischemia in survivors of acute myocardial infarction: a prospective, randomized pilot study.

Authors:  H A Dakik; N S Kleiman; J A Farmer; Z X He; J A Wendt; C M Pratt; M S Verani; J J Mahmarian
Journal:  Circulation       Date:  1998-11-10       Impact factor: 29.690

9.  Quantitative severity of stress thallium-201 myocardial perfusion single-photon emission computed tomography defects in one-vessel coronary artery disease.

Authors:  L Matzer; H Kiat; K Van Train; G Germano; M Papanicolaou; G Silagan; N Eigler; J Maddahi; D S Berman
Journal:  Am J Cardiol       Date:  1993-08-01       Impact factor: 2.778

10.  High reproducibility of myocardial perfusion defects in patients undergoing serial exercise thallium-201 tomography.

Authors:  J J Mahmarian; L A Moyé; M S Verani; M F Bloom; C M Pratt
Journal:  Am J Cardiol       Date:  1995-06-01       Impact factor: 2.778

View more
  9 in total

1.  Detecting changes in serial myocardial perfusion SPECT: a simulation study.

Authors:  Tracy L Faber; Jan Modersitzki; Russell D Folks; Ernest V Garcia
Journal:  J Nucl Cardiol       Date:  2005 May-Jun       Impact factor: 5.952

2.  Monitoring effectiveness of medical therapy in 2006.

Authors:  Ronald G Schwartz; Mark A Kudes
Journal:  J Nucl Cardiol       Date:  2006 Mar-Apr       Impact factor: 5.952

3.  Effect of changes in perfusion defect size during serial regadenoson myocardial perfusion imaging on cardiovascular outcomes in high-risk patients.

Authors:  Stephanie El-Hajj; Wael A AlJaroudi; Ayman Farag; Steven Bleich; Padma Manaoragada; Ami E Iskandrian; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2015-05-28       Impact factor: 5.952

4.  Does imaging-guided selection of patients with ischemic heart failure for high risk revascularization improve identification of those with the highest clinical benefit?: Myocardial imaging should not exclude patients with ischemic heart failure from coronary revascularization.

Authors:  Eric J Velazquez
Journal:  Circ Cardiovasc Imaging       Date:  2012-03       Impact factor: 7.792

Review 5.  Assessing the prognostic implications of myocardial perfusion studies: identification of patients at risk vs patients who may benefit from intervention?

Authors:  Paul Cremer; Rory Hachamovitch
Journal:  Curr Cardiol Rep       Date:  2014-04       Impact factor: 2.931

6.  Gated SPECT imaging to detect changes in myocardial blood flow during progressive coronary occlusion.

Authors:  Timothy F Christian; Kevin Peters; Bradly Keck; Jill Allen; Thomas Owens; Babul Borah
Journal:  Int J Cardiovasc Imaging       Date:  2007-08-17       Impact factor: 2.357

Review 7.  Noninvasive monitoring of medical therapy.

Authors:  Mark A Kudes; Ronald G Schwartz
Journal:  Curr Cardiol Rep       Date:  2006-03       Impact factor: 2.931

Review 8.  Myocardial perfusion scintigraphy: the evidence.

Authors:  S R Underwood; C Anagnostopoulos; M Cerqueira; P J Ell; E J Flint; M Harbinson; A D Kelion; A Al-Mohammad; E M Prvulovich; L J Shaw; A C Tweddel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02       Impact factor: 9.236

9.  Ischaemia change with revascularisation versus medical therapy in reduced ejection fraction.

Authors:  Robert J Mentz; Mona Fiuzat; Linda K Shaw; Afshin Farzaneh-Far; Christopher M O'Connor; Salvador Borges-Neto
Journal:  Open Heart       Date:  2015-08-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.